Jeong, H.; Choi, B.H.; Park, J.; Jung, J.-H.; Shin, H.; Kang, K.-W.; Quan, Y.H.; Yu, J.; Park, J.-H.; Park, Y.;
et al. GCC2 as a New Early Diagnostic Biomarker for Non-Small Cell Lung Cancer. Cancers 2021, 13, 5482.
https://doi.org/10.3390/cancers13215482
AMA Style
Jeong H, Choi BH, Park J, Jung J-H, Shin H, Kang K-W, Quan YH, Yu J, Park J-H, Park Y,
et al. GCC2 as a New Early Diagnostic Biomarker for Non-Small Cell Lung Cancer. Cancers. 2021; 13(21):5482.
https://doi.org/10.3390/cancers13215482
Chicago/Turabian Style
Jeong, Hyesun, Byeong Hyeon Choi, JinA Park, Jik-Han Jung, Hyunku Shin, Ka-Won Kang, Yu Hua Quan, Jewon Yu, Ji-Ho Park, Yong Park,
and et al. 2021. "GCC2 as a New Early Diagnostic Biomarker for Non-Small Cell Lung Cancer" Cancers 13, no. 21: 5482.
https://doi.org/10.3390/cancers13215482
APA Style
Jeong, H., Choi, B. H., Park, J., Jung, J.-H., Shin, H., Kang, K.-W., Quan, Y. H., Yu, J., Park, J.-H., Park, Y., Choi, Y., Kim, H. K., & Hong, S.
(2021). GCC2 as a New Early Diagnostic Biomarker for Non-Small Cell Lung Cancer. Cancers, 13(21), 5482.
https://doi.org/10.3390/cancers13215482